Seminars in nuclear medicine
Journal
Overview
publication venue for
-
Determination of age-related changes in structure and function of skin, adipose tissue, and skeletal muscle with computed tomography, magnetic resonance imaging, and positron emission tomography..
37.
2007
-
Overview of Prospective Investigation of Pulmonary Embolism Diagnosis II..
32.
2002
-
Pharmacologic intervention in cardiovascular nuclear medicine procedures..
11.
1981
-
Physiologic Intervention in Cardiovascular Nuclear Medicine..
11.
1981
-
Radioimmunoassay: review of basic principles..
5.
1975
-
Guest Editorial..
46.
2016
-
Hypoxia imaging. Guest editorial..
45.
2015
-
Guest Editorial: new PET radiopharmaceuticals as molecular imaging probes..
41.
2011
-
Current status of radiolabeled peptides in nuclear medicine diagnosis and therapy..
32.
2002
-
Cardiac Imaging With 123I-meta-iodobenzylguanidine and Analogous PET Tracers: Current Status and Future Perspectives.
2020
-
Targeted Radionuclide Therapy: A Historical and Personal Review.
2019
-
Innovations in Nuclear Imaging Instrumentation: Cerenkov Imaging.
2018
-
I-131 Metaiodobenzylguanidine Therapy of Pheochromocytoma and Paraganglioma.
2016
-
Novel Approaches to Thyroid Cancer Treatment and Response Assessment.
2016
-
A Perspective of the Future of Nuclear Medicine Training and Certification.
2016
-
The Potential of Metabolic Imaging.
2016
-
Radioiodinated metaiodobenzylguanidine (MIBG): radiochemistry, biology, and pharmacology.
2011
-
A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
2011
-
Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
2011
-
Lymph node dissection in papillary thyroid carcinoma.
2011
-
Similarities and differences in follicular cell-derived thyroid cancer management guidelines used in Europe and the United States.
2011
-
Thyroid cancer--indications and opportunities for positron emission tomography/computed tomography imaging.
2011
-
PET/CT Imaging and Radioimmunotherapy of Prostate Cancer.
2011
-
Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors.
2010
-
Hybrid imaging (SPECT/CT and PET/CT): improving therapeutic decisions.
2009
-
Clinically proven radiopharmaceuticals for infection imaging: mechanisms and applications.
2009
-
Positron emission tomography scans obtained for the evaluation of cognitive dysfunction.
2008
-
Respiratory motion in positron emission tomography/computed tomography: a review.
2008
-
Fundamentals of molecular imaging: rationale and applications with relevance for radiation oncology.
2008
-
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
2007
-
Positron emission tomography for prostate, bladder, and renal cancer.
2004
-
Variants and Pitfalls in PET/CT Imaging of Gastrointestinal Cancers.
2021
-
Evaluation of hypoxia with copper-labeled diacetyl-bis(N-methylthiosemicarbazone).
2015
-
Accuracy and precision of radioactivity quantification in nuclear medicine images.
2012
-
The next generation of positron emission tomography radiopharmaceuticals in oncology.
2011
-
Perfusion lung scintigraphy for the diagnosis of pulmonary embolism: a reappraisal and review of the Prospective Investigative Study of Acute Pulmonary Embolism Diagnosis methods.
2008
-
Small-scale dosimetry: challenges and future directions.
2008
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)